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Background: There is now compelling evidence that epigenetic modifications link adult disease susceptibility to
environmental exposures during specific life stages, including pre-pubertal development. Animal studies indicate
that bisphenol A (BPA), the monomer used in epoxy resins and polycarbonate plastics, may impact health through
epigenetic mechanisms, and epidemiological data associate BPA levels with metabolic disorders, behavior
changes, and reproductive effects. Thus, we conducted an environmental epidemiology study of BPA exposure
and CpG methylation in pre-adolescent girls from Gharbiah, Egypt hypothesizing that methylation profiles exhibit
exposure-dependent trends.
Methods: Urinary concentrations of total (free plus conjugated) species of BPA in spot samples were quantified for
60 girls aged 10 to 13. Genome-wide CpG methylation was concurrently measured in bisulfite-converted saliva
DNA using the Infinium HumanMethylation27 BeadChip (N = 46). CpG sites from four candidate genes were
validated via quantitative bisulfite pyrosequencing.
Results: CpG methylation varied widely among girls, and higher urinary BPA concentrations were generally
associated with less genomic methylation. Based on pathway analyses, genes exhibiting reduced methylation with
increasing urinary BPA were involved in immune function, transport activity, metabolism, and caspase activity. In
particular, hypomethylation of CpG targets on chromosome X was associated with higher urinary BPA. Using the
Comparative Toxicogenomics Database, we identified a number of candidate genes in our sample that previously
have been associated with BPA-related expression change.
Conclusions: These data indicate that BPA may affect human health through specific epigenomic modification of
genes in relevant pathways. Thus, epigenetic epidemiology holds promise for the identification of biomarkers from
previous exposures and the development of epigenetic-based diagnostic strategies.
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The developmental origins of health and disease (DOHaD)
hypothesis postulates that environmental and nutritional
factors influence developmental plasticity during critical
periods of development, thereby altering susceptibility
to diseases later in life [1-3]. Increasingly, this emerging
field of research points to the epigenome as an important* Correspondence: ddolinoy@umich.edu
1Department of Environmental Health Sciences, School of Public Health,
University of Michigan, Ann Arbor, MI, USA
Full list of author information is available at the end of the article
© 2013 Kim et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormodifier of disease susceptibility. Although the epigenome
is vulnerable to environmental perturbations during mul-
tiple points in life, it is particularly susceptible during
embryogenesis, neonatal development, and adolescence. For
example, similar to the rapid synthetic rate of DNA in early
development, during the pre-pubertal period, mammary
growth is highly proliferative and tightly regulated [4-8],
making pre-adolescent females especially vulnerable to en-
vironmental insults acting via an epigenetic mechanism.
Accumulating work suggests that exposure to endocrine-
active compounds (EACs), including bisphenol A (BPA),. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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via epigenetic mechanisms. Methylation studies conducted
by Li et al. on the estrogenic pharmaceutical agent diethyl-
stilbestrol (DES) observed hypomethylation in two critical
DNA control regions in mice exposed in utero or in the
perinatal period [9,10]. Exposure to the anti-androgenic
fungicide vinclozolin, the estrogenic pesticide methoxy-
chlor, or a mixture of plastic compounds during repro-
gramming of the germ line has been linked with epigenetic
alterations that are inherited transgenerationally even in
the absence of continued exposure [11-15]. Further, BPA,
a high-production volume monomer used in the manu-
facture of polycarbonate plastic and epoxy resin, has been
associated with epigenetic alterations following developmen-
tal exposure [16-19]. Using a rat model, Ho et al. observed
multiple changes in gene-specific DNA methylation patterns
in the adult male prostate, including hypomethylation of
the phosphodiesterase type 4 variant 4 (Pde4d4) gene
following neonatal exposure to low BPA concentration
(10 μg/kg of body weight BPA) [16]. Using the Avy mouse
model, we have shown that maternal dietary exposure to
physiologically relevant concentrations of BPA results in
altered DNA methylation at two metastable loci [17,19].
Moreover, restoration of normal methylation patterns
occurs with maternal supplementation of genistein or
methyl donors including folate, choline, betaine, and vita-
min B12 [17,20].
Recent toxicological and epidemiological data warrant
the identification of epigenetic biomarkers associated with
BPA exposure. For example, rodent studies have associ-
ated environmentally relevant pre- or perinatal BPA ex-
posure with higher body weight, increased breast and
prostate cancer susceptibility, altered reproductive func-
tion, and other chronic health effects [21]. In 2008, the
first comprehensive human epidemiological study associ-
ated higher urinary BPA concentrations with increased
risk for cardiovascular disease, type 2 diabetes, and liver
enzyme abnormalities [22], and recent data correlated urin-
ary BPA concentrations and obesity in U.S. children [23].
An analysis of 2003–04 National Health and Nutrition
Examination Survey (NHANES) data found that the half
life of BPA in the human body is longer than would be
expected from acute exposure studies, suggesting that
BPA either bioaccumulates in the body or BPA exposure
occurs through non-dietary sources or both [24]. Hence,
it is now hypothesized that life course exposure to en-
vironmental pollutants, such as BPA, are linked to adult
disease, such as breast cancer [25].
Building upon ongoing epidemiological and exposure
studies in Gharbiah, Egypt [26-30], we correlated urinary
concentrations of total (free plus conjugated) species of
BPA in spot samples with genome-wide CpG methyla-
tion levels in concurrently collected saliva DNA samples.
We conducted an environmental epidemiology study ofBPA exposure and CpG methylation in pre-adolescent girls
hypothesizing that methylation profiles exhibit exposure-
dependent trends.
Utilizing a semi-unbiased, quantitative genome-wide
methylation array, which evaluates 27,543 individual CpG
sites targeting 14,475 genes, we identified 57 agnostic and
35 biologically prioritized candidate CpG sites as well as
gene pathways differentially methylated with respect to
BPA concentrations. Four candidate genes were further
validated using bisulfite pyrosequencing, a sensitive and
quantitative method of DNA methylation detection. Using
the Comparative Toxicogenomics Database (CTD) [31-33],
we identified previously published candidate genes with up-
regulated expression associated with BPA and found that
many of the targets had BPA-associated hypomethylation
in our sample set, and vice versa.
Methods
Study population
This study originated from a pilot study addressing en-
vironmental exposures in a developing country, and our
study population was previously described in Nahar et al.
[27]. Briefly we recruited healthy females 10–13 years of
age living in either rural (N = 30) or urban (N = 30) areas
of the Gharbiah province of Egypt, located 90 kilometers
north of Cairo. We obtained written informed consent
from the mother of each participant, and approval from the
Institutional Review Boards of the University of Michigan
and the Gharbiah Cancer Society were obtained before
starting the study. The involvement of the Centers for
Disease Control and Prevention (CDC) laboratory was
limited and determined not to constitute engagement in
human subject research. The average age of menarche
in Egypt is 12.44 ± 1.3, and all study participants were
pre-menstrual, as ascertained by asking the each mother
about any prior menstrual cycles of her daughter [34].
To reduce variability arising from various exposures
throughout the day, the participants provided one spot
urine sample during the time period between noon to
4 pm and were measured for height, weight, waist, and
hip circumference by trained nurses, using standardized
techniques as previously described and validated [35,36].
In brief, each anthropometric measurement was taken
twice. If the difference in the height measurements was
> 0.5 centimeters (cm); if the difference in weight was
> 0.2 kilograms; if the difference in waist circumference
was > 0.5 cm; or if the difference in hip circumference
was > 0.5 cm, then a third measurement was taken. We
discarded the most discrepant value and averaged the other
two. The Division of Laboratory Sciences of the National
Center for Environmental Health at the CDC deter-
mined the urinary concentrations of total (free plus
conjugated species) BPA as previously described [27,37]. An
interviewer administered a lifestyle and diet questionnaire
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posure, and field-collected anthropometric measurements
were acquired. The questionnaire, entitled “Comparison
of Xenoestrogen Levels Among Prepubertal Females in
Urban and Rural Gharbiah, Egypt,” contained questions
addressing residential history, personal care product
usage, family history of cancer, use of canned foods,
breast feeding status, and food preparation and storage
behaviors.
Saliva DNA was concurrently collected using the Oragene
DNA Self-Collection Kit (DNA Genotek, Ontario, Canada).
The Oragene kit allows for long-term DNA storage at
room temperature with little or no DNA degradation. Total
genomic DNA was isolated from saliva samples using
Oragene-DNA Self-Collecting kit standard protocols.
Bisulfite conversion was carried out on 600 ng of gen-
omic DNA using the manufacturer’s protocol (EZ DNA
Methylation-Direct Kit, Zymo Research Corp., Orange,
CA) for genome-wide methylation assessment using
the Illumina Infinium HumanMethylation27 BeadChip
platform (Illumina, San Diego, CA). For pyrosequencing
validation 600 ng of DNA was bisulfite converted using
the Qiagen EpiTect Bisulfite Conversion kit (Qiagen,
Valencia, CA).
Genome-wide DNA methylation discovery
Genome-wide DNA methylation was assessed with the
Infinium HumanMethylation27 BeadChip (Illumina) per-
formed at the University of Michigan DNA Sequencing
Core facility in accordance with manufacturer’s instruc-
tions as previously published [38]. Samples exhibiting
various BPA concentrations (ranging from non-detect to
12 ng/mL) were randomly applied to each of the 12-sample
arrays to avoid bias by batch effect. The Illumina
BeadStudio Software provided estimates, termed beta
values or β-scores, of the percent methylation for each
probe site based on the Cy3 and Cy5 intensities. We
utilized a previously described normalization strategy
that improves the correlation among replicate samples
and tends to increase the level of significance when the
methylation percentages are compared between groups [39].
In order to maximize power to detect methylation
differences specific to higher BPA concentrations, we
performed analysis both categorizing the samples into
three groups: BPA-low (n = 22), BPA-intermediate (n = 14),
and BPA-high (n = 10) and treating BPA as a continuous
variable. First, in the categorization strategy, samples were
classified as BPA-low if the BPA measurement was less
than 1 ng/mL; BPA-high if BPA measurement was greater
than 2 ng/mL; and BPA-intermediate for remaining
samples. The observed BPA concentrations within our
Egyptian cohort were relatively low, ranging from below
the limit of detection (LOD) to 12 ng/mL. To identify differ-
ential methylation associated with high BPA concentrations,we performed the categorical analysis focusing on the tails
of the BPA distribution. We used an empirical Bayesian
moderated t-test to assess significance between the per-
cent methylation in BPA-high versus BPA-low samples,
which improves results for studies of small sample size
[40]. Those with p-value < 0.05 with average ß-score differ-
ence greater than 5% were reported as candidate sites. To
identify differential methylation associated with the highest
concentrations of BPA in this cohort, the analysis de-
scribed above was repeated using a more stringent cutoff
for the BPA-high group (n = 5, where urinary BPA con-
centrations are greater than 2.60 ng/mL, the median
concentration of age and gender matched individuals from
NHANES 2009–2010) (Additional file 1: Table S1). The
list of significant CpG sites at candidate genes from the
above analysis was compared with BPA-interacting genes
acquired from CTD and used for the pathway enrich-
ment analysis.
Bioinformatics analyses
All statistical analyses were performed with R Statistical
Software (version 2.10.1). CpG sites that failed on 10% of
samples were not included in subsequent analyses. Using
the LIMMA package (Version 3.4.4) in R, BPA-dependent
differential methylation regions among Egyptian girls
were examined using covariates including hybridization
date, age, breast-fed status, body mass index (BMI), and
specific gravity to adjust for urinary dilutions, and log-
transformed urinary concentrations of BPA. As is stand-
ard in microarray analyses, empirical Bayesian variance
methods were incorporated to perform site-specific mod-
erated t-tests [40]. The linear model used for each individ-
ual CpG site was as follows:
% Methylation ¼ β0 þ breast–fed status
þ hybridization date
þ β1 log BPAð Þð Þ þ β2 ageð Þ
þ β3 BMIð Þ
þ β4 urinary correctionð Þ
RPMM clustering analysis
The Recursively Partitioned Mixture Model (RPMM)
clustering analysis in R software program was performed
on the top 200 most variable CpG sites using the glcTree
function, which performs Gaussian latent class model-
ing. The only non-default parameter used during the
analysis was for the level of verbosity, which was set at 0
(default is at 2). The glcTree clustering analysis sepa-
rated 46 samples into 3 leaf classes (clusters 1, 2, and 3).
Logistic regression-based pathway enrichment analysis
An enrichment analysis was performed using logistic
regression-based pathway enrichment analysis tool (LRpath)
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senting 27,543 sites generated from the R statistical ana-
lysis described above was reformatted to contain Entrez
gene IDs, p-values, and fold-changes in tab-delimited text
file format. Gene Ontology (GO) terms and pathway con-
cept types were selected (Biocarta pathway, Edinburgh
Human Metabolic Network (EHMN) metabolic pathway,
GO biological process, cellular component, and molecu-
lar function, Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway, and Panther pathway) for enrichment
analysis in LRpath web-application. For both dichotomous
comparison of low- versus high-BPA sample groups and
the continuous linear models, LRpath was performed
using the directional option with default settings, to dis-
tinguish pathways enriched with hyper- versus hypo-
methylated sites.
Gene set enrichment analysis
Positional gene set enrichment analysis was performed
using Gene Set Enrichment Analysis (GSEA) to determine
statistical over-representation of BPA-concentration spe-
cific epigenetic marks within chromosomal cytogenic bands.
The differences in average β-score of each probe (N =
27,543) between BPA-low and BPA-high groups were
pre-ranked and subjected to GseaPreranked analysis tool.
After collapsing features into gene symbols, a total of
14,474 genes were represented, and the enrichment among
240 cytogenic band sets were tested with default setting.
Comparative toxicogenomics database (CTD)
The publicly available Comparative Toxicogenomics Data-
base (CTD) combines manually curated information from
peer-reviewed articles on environmental chemicals, inter-
acting genes, and known associated health effects in human
as well as in animal models [31-33]. The tool allows in-
vestigators to quickly query their epigenomics-derived
gene list with curated genes associated with a particular
exposure or phenotypic endpoint of interest. A list of 903
BPA-interacting genes in humans was acquired using a
chemical-gene interaction query using Bisphenol-A as a
search term, and after mapping the list to the genes present
on the BeadChip, 657 unique genes represented by 1,355
probes remained for downstream analysis.
Validation by pyrosequencing
CpG methylation at specific loci of the biologically-
prioritized and agnostic candidates was validated by
pyrosequencing using 2 ul bisulfite converted DNA.
PCR and sequencing primers were designed in-house
using PyroMark software are listed in Additional file 1:
Table S2. The PCR products were run on a 1.5% agarose
gel to ensure PCR quality, correct product length, and
lack of contamination. Pyrosequencing was performedfollowing the manufacturer’s protocol on a PyroMark
MD (Qiagen).
Results
Characterization of DNA methylation across Egyptian girls
High-throughput analysis of DNA methylation in a co-
hort of Egyptian girls was performed using the Infinium
HumanMethylation27 BeadChip (Illumina) containing
27,543 CpG sites targeting 14,475 gene promoters, in-
cluding > 200 cancer-related and imprinted genes and
110 microRNAs [43-45]. To demonstrate experimental
consistency in our research setting, we selected four sam-
ples with the most abundant genomic DNA and profiled
them on the bead array in duplicate. All duplicates were
shown to be highly correlated with a median correlation
coefficient value of 0.98 (data not shown).
We evaluated the overall distribution of the β-score,
which indicates the level of methylation at CpG sites
(Figure 1A). Among the 27,543 probes present in all 46
samples with a significant p-value (p < 0.05), 19,985 (73%)
probes were located within annotated CpG islands, while
the remaining 7,558 (27%) probes were not. More than
half of the probes (average n = 11,700 with s.d. of 1,786)
located within CpG islands had a β-score less than 0.05
showing highly shifted distribution (Figure 1B). Probes
located outside of CpG islands displayed skewed bimodal
distributions of β-scores (Figure 1C). The secondary
peak observed on the long right tail of the distribution
in Figure 1A is likely associated with probes from CpG
island depleted regions.
Urinary BPA concentration affects CpG methylation
profiles
As described previously, urinary BPA concentrations and
variability were low in the Egyptian girls cohort compared
to age-matched females in the United States as reported in
2009–2010 National Health and Nutrition Examination
Survey (NHANES) [27]. Concentrations of urinary BPA in
Egyptian girls ranged from below the limit of detection
(LOD = 0.4 ng/ml) to 12 ng/mL (total median unadjusted:
0.70 ng/mL) compared to age-matched American girls
ranging from below the LOD to 16.1 ng/mL (median
unadjusted: 2.60 ng/mL). Comparing samples with BPA-
low and BPA-high concentrations as a dichotomous trait
resulted in 1,439 differentially methylated sites (Figure 2A)
with p-value less than 0.05 and 171 sites with a p-value
less than 0.01, compared to 190 differentially methylated
sites by age and 444 differentially methylated sites by BMI.
The overall difference in average β-score between the two
BPA exposure groups was not significant (0.177 vs. 0.180);
however, when we limited the analysis to those sites that
are differentially methylated, there were a greater number
of hypo- (178 with at least 5% change in β-score) com-
pared to hyper-methylated (54 with at least 5% change in
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Figure 1 β-score distribution in the HumanMethylation27 BeadChip in the presence and absence of CpG islands in 1 randomly chosen
sample. All samples display similar distributions as shown above. (A) The first histogram represents the β-score frequency of all probes. (B) The
β-score frequency of the probes located within CpG islands is graphed. (C) The β-score frequency of the probes located outside of CpG islands
is graphed.
Kim et al. Environmental Health 2013, 12:33 Page 5 of 15
http://www.ehjournal.net/content/12/1/33β-score) sites in the BPA-high group compared to the
BPA-low group (Additional file 2: Figure S1). The top
57 agnostic candidate genes with average β-score differ-
ence greater than 5% (ranges from −0.11 to 0.12) and a
p-value < 0.05 are listed in Additional file 1: Table S3.
Using Recursively Partitioned Mixture Model (RPMM)











































Figure 2 Histogram of p-values (bin = 0.1) in methylation analysis usi
modeling using LIMMA package in R software with BPA as a (A) dichoexamined the patterns of differential methylation using
the top 200 most variable CpG sites (Figure 3). The
resulting cluster was divided into 3 major leaf nodes:
clusters 1, 2, and 3. Cluster 1 displayed a hypomethyation
signature, and more than half of BPA-high samples were
in this cluster (Figure 3A and B). While the least number
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Figure 3 The 200 most variable CpG sites from 46 samples were clustered using Recursively Partitioned Mixture Model (RPMM) for
Beta and Gaussian Mixtures from R package, a model-based clustering algorithm that returns a hierarchy of classes, similar to
hierarchical clustering and finite mixture models. (A) RPMM clustering divided 46 samples into 3 clusters (1, 2, and 3), containing 12, 15, and
19 samples, respectively. (B) More than half of the BPA-high samples were clustered within cluster 1, while BPA-low and –intermediate samples
were more evenly distributed across all 3 clusters.
Kim et al. Environmental Health 2013, 12:33 Page 6 of 15
http://www.ehjournal.net/content/12/1/33contained the greatest number of BPA-low and -intermediate
samples. In general, BPA-low and -intermediate samples
showed similar methylation profiles in all resulting leaves,
indicating similarity in CpG methylation between these
two groups. Lastly, cluster 3, which exhibited a high methy-
lation signature was evenly composed of samples from
all three groups (Figure 3). The tree plot of mean-centered
β-scores of these top 200 most variable CpG sites is pro-
vided in Additional file 2: Figure S2.
An enrichment analysis on the dichotomous model
candidate sites was performed using LRpath with resulting
p-value output from R statistical analysis [42]. Highly
enriched GO molecular functions included various recep-
tor and receptor binding activities of G-protein-coupled
receptor (p-value < 1.91e-5 and FDR < 2.00e-3), chemokine
(p-value < 2.48e-5 and FDR < 2.02e-3), G-protein chemo-
attractant, and other sensory-related receptors (Table 1
and Additional file 1: Table S4). The cytokine-related
concepts were further supported by a top-ranked re-
lated KEGG pathway concept (p-value < 3.06e-6 and
FDR < 5.69e-4). Other top KEGG pathways were involved
with metabolism and biosynthesis activities (Additional
file 1: Table S4), and GO terms were enriched with im-
mune and inflammatory responses. Interestingly, these
concepts were enriched among the hypomethylated gene
sets, indicating possible induced activity with higher BPA
concentrations. The enrichment analysis using a stringentBPA-high group (N = 5), whose BPA measurements were
above the mean of age-matched American girls, yielded
similar findings, with immune-related and metabolic
concepts enriched among hypomethylated genes.
As a second approach, modeling BPA as a continuous
linear model utilizing all 46 samples identified 3,042 dif-
ferentially methylated sites with a p-value < 0.05 and 523
sites with a p-value < 0.01 (Figure 2B and Additional file 1:
Table S3). Seventy-six percent of the continuous model
sites overlap with the initial categorical modeling hits.
We uploaded significant CpG sites from the continuous
approach to LRpath for gene set enrichment testing,
and observed a high resemblance between dichotomous
and continuous LRpath pathways. For example, highly
enriched GO molecular functions and pathways included
receptor binding activities such as G-protein, chemo-
kine, and sensory-related, as well as immune, and in-
flammatory responses (Table 1 and Additional file 1:
Table S4). Significantly enriched GO and pathway terms
among hypermethylated sites were ribosome-related,
such as structural constituent of ribosome, rRNA metabolic
process, rRNA processing, and ribosome biogenesis and
assembly. On the other hand, enriched concepts among
hypomethylated sites included metabolite concepts such
as progesterone (p-value < 2.25e-7 and FDR < 1.04e-4),
testosterone (p-value < 5.41e-7 and FDR < 1.25e-4), and
estradiol-17beta (p-value < 2.25e-6 and FDR < 2.59e-4).
Table 1 LRpath analysis reveals that cytokine and hormone activity, immune response, and metabolic processes
among the top enriched concepts within differentially methylated genes
Dichotomous model - pathway (FDR <0.2, P-value <0.02)
Name Concept type #Genes Coeff Odds ratio P-Value FDR Enriched
Cytokine-cytokine receptor interaction KEGG Pathway 229 −0.200253028 0.288086617 3.06E-06 5.69E-04 Down
Metabolism of xenobiotics by cytochrome P450 KEGG Pathway 61 −0.287221818 0.167801921 1.58E-04 0.014739788 Down
Vitamin A (retinol) metabolism EHMN Pathway
Gene
25 −0.428286702 0.069834019 3.14E-04 0.015401391 Down
N-Glycan biosynthesis KEGG Pathway 44 0.359631955 9.346216996 0.001289861 0.079971357 Up
Proteogylcan biosynthesis EHMN Pathway
Gene
21 −0.40681778 0.079801493 0.001359963 0.0333191 Down
Oxidative phosphorylation KEGG Pathway 101 0.206370232 3.605679051 0.004079267 0.176257686 Up
C21-Steroid hormone metabolism KEGG Pathway 12 −0.42731737 0.07025597 0.00473811 0.176257686 Down
Proteasome KEGG Pathway 21 0.442939628 15.68486443 0.006686061 0.18372292 Up
Ribosome KEGG Pathway 59 0.255415299 4.890555948 0.006914303 0.18372292 Up
Natural killer cell mediated cytotoxicity KEGG Pathway 116 −0.157029295 0.376862256 0.008222671 0.188057588 Down
Dichotomous model - GO (FDR <0.01, P-value <5e-4, Odds ratio >5)
Name Concept type #Genes Coeff Odds ratio P-value FDR Enriched
Epidermis development GO Biological
Process
120 −0.288785876 0.166178787 7.22E-08 2.83E-05 Down
Ectoderm development GO Biological
Process
130 −0.27220051 0.184220938 1.69E-07 4.41E-05 Down
Sensory perception of chemical stimulus GO Biological
Process
81 −0.326598184 0.131377584 2.59E-07 5.80E-05 Down
Digestion GO Biological
Process
85 −0.314243619 0.141861941 4.72E-07 8.22E-05 Down




161 0.282212002 5.776725456 5.25E-07 8.23E-05 Up
Regulation of homeostatic process GO Biological
Process
18 −0.534094322 0.03618224 2.19E-06 3.12E-04 Down
G-protein-couples receptor binding GO Molecular
Function
69 −0.298251857 0.156684914 1.91E-05 0.001995771 Down
Chemokine binding GO Molecular
Function
26 −0.431856927 0.068301636 2.48E-05 0.002021324 Down
Sensory perception of smell GO Biological
Process
56 −0.318324204 0.138309662 2.90E-05 0.002387889 Down
Serine-type endopeptidase inhibitor activity GO Molecular
Function
73 −0.285841884 0.169247136 2.90E-05 0.002021324 Down
Continuous model - pathway (FDR <0.2, P-value <0.02)
Name Concept type #Genes Coeff Odds ratio P-Value FDR Enriched
Cytokine-cytokine receptor interation KEGG Pathway 229 −0.205604496 0.278663207 9.68E-09 1.80E-06 Down
Metabolism of xenobiotics by cytochrome P450 KEGG Pathway 61 −0.2927432 0.162141761 4.33E-06 4.03E-04 Down
Complement and coagulation cascades KEGG Pathway 66 0.25256689 0.208127535 5.11E-05 0.003167145 Down
Plaminogen activating cascade Panther Pathway 13 −0.497645229 0.045380623 6.32E-05 0.114613557 Down
Cytokines and Inflammatory Response Biocarta Pathway 29 −0.33471697 0.124913374 195E-04 0.035217055 Down
Ribosome KEGG Pathway 59 0.287062223 5.953499593 2.21E-04 0.010264183 Up
Vitamin A (retinol) metabolism EHMN Pathway
Gene
25 −0.385600917 0.091048898 2.51E-04 0.012317017 Down
Autoimmune thyroid disease KEGG Pathway 47 −0.26174305 0.196590877 3.38E-04 0.012575822 Down
Oxidative phosphorylation KEGG Pathway 101 0.209255664 3.670918657 4.30E-04 0.013316379 Up
Asthma KEGG Pathway 26 −0.321259111 0.135809858 6.79E-04 0.015209508 Down
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Table 1 LRpath analysis reveals that cytokine and hormone activity, immune response, and metabolic processes
among the top enriched concepts within differentially methylated genes (Continued)
Continuous model - GO (FDR <0.01, P-value <5e-4, Odds ratio >5)
Name Concept type #Genes Coeff Odds ratio P-Value FDR Enriched
Sensory perception of chemical stimulus GO Biological
Process
81 −0.378994195 0.094865006 8.35E-14 6.54E-11 Down
Digestion GO Biological
Process
85 −0.332578826 0.126584265 6.03E-11 2.10E-08 Down
Epidermis development GO Biological
Process
120 −0.281910372 0.17343325 2.06E-10 5.38E-08 Down
Ectoderm development GO Biological
Process
130 −0.26538019 0.192197099 7.20E-10 1.34E-07 Down
Sensory perception of smell GO Biological
Process
56 −0.372825845 0.09857215 7.72E-10 1.34E-07 Down
Acute inflammatory response GO Biological
Process
69 −0.321398071 0.135692626 1.28E-08 1.55E-06 Down
Serine-type endopeptidase inhibitor activity GO Molecular
Function
73 −0.304550109 0.150670556 3.09E-08 2.71E-06 Down
olfactory receptor activity GO Molecular
Function
42 −0.377710874 0.095624611 3.89E-08 2.71E-06 Down
Immunoglobulin mediated immune response GO Biological
Process
50 −0.352071918 0.11214204 5.47E-08 5.72E-06 Down
B cell mediated immunity GO Biological
Process
51 −0.34665743 0.115979703 7.23E-08 7.08E-06 Down
Continuous model - metabolite
Progesterone Metabolite 34 −0.456431331 0.058628061 2.25E-07 1.04E-04 Down
Testerone Metabolite 53 −0.364806957 0.103608877 5.41E-07 1.25E-04 Down
Trichloroethanol Metabolite 46 −0.365998732 0.102844341 2.20E-06 2.59E-04 Down
Estradiol-17beta Metabolite 47 −0.362340859 0.105208999 2.25E-06 2.59E-04 Down
This table depicts the top 10 GO and pathway concepts in both the dichotomous and continuous analyses.
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9.5 respectively.
Higher BPA concentration is associated with
hypomethylation of X-chromosome CpG sites
Using the dichotomous categorical model, we investigated
the chromosomal location of the differentially methylated
CpG sites. The differences in mean β-score of each probe
between BPA-low and BPA-high groups were pre-ranked
and subjected to the GseaPreranked analysis [46]. Several
cytogenic regions on chromosome X, including both the p
and q arms (Xq21, Xp11, Xq24, etc.) were significantly
enriched (p-value < 0.05) with hypomethylated probes in
BPA-high vs. BPA-low samples (Figure 4 and Additional
file 1: Table S5). No regions from chromosome X were
enriched with hypermethylated genes in BPA-high vs.
BPA-low groups, and none of the autosomes were signifi-
cantly enriched in either direction. Chromosome X en-
richment is also observed, even when BPA-intermediate
group is added to the analysis and combined with the
BPA-low group (data not shown). However, when the
BPA-intermediate group is combined with BPA-high groupto be tested against BPA-low group, the enrichment within
chromosome X is no longer significant.
Imprinted gene methylation is not broadly affected by
BPA concentrations
The methylation patterns observed in differentially meth-
ylated regions (DMRs) of imprinted regions in the hu-
man genome play an important role in parent-of-origin
monoallelic gene expression. We compared the methy-
lation level of imprinted genes obtained from the cata-
logue of parent-of-origin effects (http://igc.otago.ac.nz/
home.html). The methylation differences of 34 unique
imprinted genes measured by 233 probes on BeadChip
in BPA-low and BPA-high samples were evaluated, and
none were found to be differentially methylated by BPA
exposure group (Additional file 2: Figure S3A) among
Egyptian pre-adolescent girls, with the exception of Necdin
(NDN). Among six probes (999, 776, 80, and 77 bps down-
stream, and 308 and 170 bps upstream of TSS) targeting
the promoter of NDN, one CpG site (308 bp upstream
from TSS) was significantly less methylated in BPA-high
samples (p-value < 0.02) with average methylation
Xq21 Xp11 Xq28
Hyper                                                 Hypo 
                                               in BPA-High
Hyper                                                 Hypo 
                                               in BPA-High
Hyper                                                 Hypo 
                                               in BPA-High
p-value<0.0001 p-value<0.004 p-value<0.047
Figure 4 In the dichotomous model analysis, multiple regions in chromosome X were enriched with hypomethylated genes in BPA-high
vs. BPA-low groups.
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Neighboring CpG sites (77 bp downstream and 170 bp
upstream of TSS) were not differentially methylated.
Differential methylation is associated with known BPA-
interaction genes
The publicly available Comparative Toxicogenomics Data-
base (CTD) provides manually curated information on
environmental chemicals, interacting genes, and associ-
ated health effects in human as well as animal models
[31-33]. A list of 903 genes in humans whose expression
levels are known to be affected by BPA was acquired
using a chemical-gene interaction query, yielding 333
genes with increased and 257 genes with decreased level
of expression upon BPA exposure. The directionality of
the expression changes in remaining 313 genes was not
available. A total of 657 unique genes (from 1,355 probes)
from this list were represented on the BeadChip, and the
methylation levels were compared to identify “biologically-
prioritized” candidate genes with previously characterized
altered expression by the CTD. Overall, 293 out of 1,355
sites (21.6%) were differentially methylated (p-value < 0.05)
with BPA exposure in either the dichotomous or continu-
ous model described in the Methods. The top biologically-
prioritized candidates with an average β-score difference
more than 5% are shown in Figure 5 and Additional file 1:
Table S6 (n = 35). In general, hypomethylated candi-
dates exhibit high level β-scores (above 0.5), while
hypermethylated candidates tend to have basal or low
level methylation (Figure 5).
Several hyper- and hypo-methylated genes in BPA-high
compared to BPA-low samples corresponded with ex-
pression change, adhering to the general agreement that
methylation and expression often exhibit inverse direc-
tionality. For example, the hypomethylated probes map-
ping to C11orf52, HOXA10, KIF4A, DTL, GREB1, and
NCF2 were identified in CTD to have increased expres-
sion, while the hypermethylated probes mapping to NCK1,
CSDA, and BRCA1 were reported by CTD to havedecreased expression with BPA exposure. The direction-
ality of the expression change in hypomethylated genes
including C6orf32, MMP10, HKDC1, SLC3A1, VGLL1,
and IQCH, and hypermethylated genes including INHBE,
ASPM, NRP1, ELL2, and NEDD9 was not provided in the
CTD. The expression change of the hypomethylated genes,
PLD1, AR, KATNA1, and CYP3A4, and the hypermethylated
genes, BCL2, TK1, TRIP13, and RACGAP1, was not in-
versely correlated with the methylation status.
Candidate gene validation
The high ranking CpG sites from four candidate genes,
characterized as either A) agnostic based on p-value alone
(BEX2 and cXorf23; Additional file 1: Table S3) or B) bio-
logically prioritized based on a previously established
association with BPA (HOXA10 and DTL; Additional
file 1: Table S6) were validated by quantitative bisulfite
pyrosequencing (Additional file 1: Table S2). DTL with
two CpG sites and HOXA10 with a single CpG site were
run in duplicate on all samples with sufficient DNA,
resulting in high correlation between replicates (N = 59,
including the original 46 profiled on the BeadChip). The
regions encoding BEX2 with 3 CpG sites and cXorf23 with
a single CpG site were each run in a single sample well
due to DNA quantity limitations (N = 59 including the
original 46 profiled on BeadChip).
When methylation levels were compared between
girls classified as BPA-low (<0.7 ng/mL, N = 22) to girls
classified as BPA-high (>2 ng/mL, N = 13), no significant
differences were observed at either the agnostic or bio-
logically prioritized CpG sites (data not shown). However,
when the analysis was restricted to girls with urinary con-
centrations of BPA below the limit of detection (N = 12)
compared to girls characterized as BPA-high (N = 13), a
decreasing, yet statistically non-significant, trend in DNA
methylation in all candidate CpG sites was observed in all
4 genes (Figure 6A-D). Interestingly, further dichotomiza-
tion of exposure categorization to girls with non-





























































































































































































Figure 5 Differential methylation observed in genes known to be interacting with BPA from the Comparative Toxicogenomics
Database (CTD). (A) Top candidate genes that undergo hypermethylation in BPA-high vs. BPA-low groups. (B) Top candidate genes that
undergo hypomethylation in BPA-high vs. BPA-low groups. The reported expression change in genes with the asterisk did not inversely correlate
with the methylation status.
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N = 3) revealed differential methylation with statistical sig-
nificance (p-value < 0.024) at the HOXA10 biologically-
prioritized candidate gene (Additional file 2: Figure S4).
Discussion
The effect of environmental exposures on epigenetic
regulation in human populations remains poorly under-
stood. The consequences of maternal exposure to EACs,
including BPA, on the epigenetic landscape of offspring
has been studied using animal models, and this includes
the discovery of altered DNA methylation at candi-
date metastable epialleles such as CDK5 activator-
binding protein (Cabp) and viable yellow Agouti
(Avy) alleles [17,19]. The effects of postnatal BPAexposure on the human epigenome, however, remain
largely unexplored. To date, the majority of environ-
mental epidemiology studies that incorporate epigenet-
ics have been conducted in the context of a cohort
study, where both environmental exposures and epi-
genetic outcomes are quantified in healthy populations
[47-49]. The majority of these studies have looked at
single genes or global methylation profiles. Increas-
ingly, epigenome-wide approaches are useful in iden-
tifying a broader constellation of epigenetic changes
associated with environmental exposures [50]. Here we
measured DNA methylation levels genome-wide in 46
pre-adolescent Egyptian girls with varying concentrations
of BPA exposure. The study population was homogeneous
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Figure 6 Quantitative levels of methylation for HOXA10, BEX2, CXorf23, and DTL (N = 12 for Non-detect and 13 for High-BPA for
HOXA10, CXorf23, and DTL, and N = 9 for Non-detect and N = 9 for High-BPA for BEX2).
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ure based methylation profiles.
While the overall levels of urinary BPA concentrations
of Egyptian girls were low and less variable compared to
age-matched American girls [27], we identified several
CpG sites showing differential methylation upon expos-
ure and biological pathways of interest using a genome-
wide approach. This provides support for the hypothesis
that even low concentrations of BPA exposure may be
associated with health effects via epigenetic modification,
and studies of relevant ranges of BPA exposure in hu-
man populations are warranted. These results should be
interpreted cautiously as the use of spot urine for
measuring BPA exposure is a limitation of our study.
For example, interpersonal variation in amount of waterconsumed may affect urine output. Thus, we adjusted
urine BPA concentrations using specific gravity. Simi-
larly, to reduce variability arising from exposures through-
out the day, the participants provided spot urine sample
during a specified time period between noon to 4 pm.
Additionally, previous studies on various populations
have shown that individuals are exposed to mixtures of
chemicals, potentially with similar mechanisms of action
as BPA, such as phthalates, pesticides, and heavy metals.
Future studies using more comprehensive methods of
exposure assessment, including the measurement of chem-
ical mixtures, are warranted [51].
Of interest, many previously identified pathways asso-
ciated with BPA exposure were also identified in our
analysis as top differentially methylated pathways.
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hypomethylation among genes involved in metabolism
and steroid hormones, including progesterone, testoster-
one, and estradiol. BPA is one of several widely known
EACs or xenoestrogens [52,53], and steroid hormones
are known to influence metabolism and inflammation
including various immune responses. As such, several
immune-response concepts were enriched with
hypomethylated CpG sites in girls in the BPA-high
group. In previous studies, higher cytokine activity was
observed in BPA-exposed rodents [54]. In addition, the
autoimmune thyroid disease pathway was significantly
enriched with hypomethylated genes in girls categorized
in the BPA-high group, and BPA is a known thyroid
receptor antagonist [55,56]. Genes involved in the N-
glycan biosynthesis pathway were also found to be
differentially methylated based on BPA exposure,
supporting previous work linking BPA concentrations
with insulin resistance and type II diabetes [57], For ex-
ample, N-glycans are key players mediating cell-to-cell
communication, interacting with glycan-binding pro-
teins [58], and can be attached to human insulin recep-
tor (IR) and interfere with the IR interaction with
antibodies or binding proteins by masking the surface of
IR dimers [59].
Prenatal BPA exposure has been associated with altered
DNA methylation and expression of imprinted genes in
mouse embryos [60,61]. A methylation analysis of oocytes
from CD-1 mice perinatally exposed to 20 or 40 ug
BPA/kg diet identified decreased methylation among
imprinted genes, including insulin like growth factor 2
receptor (IGF2R) and paternally expressed 3 (PEG3) [60].
When pregnant JF1 mice were exposed to 200 ug BPA/kg
diet, embryos showed a 10% difference in Slc22a18 ex-
pression compared with controls [61]. When we exam-
ined DNA methylation of 34 imprinted genes (from 233
sites) in these subjects, BPA-associated changes were not
observed in the imprinted genes, with the exception of a
single CpG site in the NDN promoter (Additional file 2:
Figure S3B). The imprinted gene, NDN, is located within
the Prader-Willi/Angelman syndrome (PWS) chromosomal
region [62]. Loss of function of this gene has been asso-
ciated with post-natal lethality [63]; thus NDN has a crit-
ical role during development. Thus, methylation profiles
at imprinted genes, while labile to nutritional and envir-
onmental influences early in development [64-66], may
remain stable and relatively resistant to environmental
factors over the life course.
DNA methylation of CpG islands acting in concert
with other epigenetic mechanisms, are known to be im-
portant in female mammalian X chromosome inactivation
and maintenance [67]. As with genomic imprinting,
chromosome X inactivation may thus be potentially
vulnerable to the effects of environmentally-inducedepigenetic reprogramming [68]. In our data, we ob-
served an enrichment of hypomethylated sites on
chromosome X with increasing BPA concentrations
(Figure 4 and Additional file 1: Table S5). One of the sig-
nificantly hypomethylated cytobands in chromosome X
was Xq13 (p-value < 0.02), where the X Inactivation Cen-
ter (XIC) is located. The XIC is known to play a role
in Xist expression, a major regulator of X inactiva-
tion. Two of the four sites validated by quantitative
bisulfite pyrosequencing were CXorf23 (Xp22.12) and
BEX2 (Xq22.1) from chromosome X. Although we were
unable to achieve robust statistical significance as seen in
the BeadChip data, we did observe a slight decrease in
DNA methylation in BPA-high samples (Figure 6). As the
girls observed in our study had low urinary BPA concen-
trations compared to age-matched American girls [27], it
will be important to further evaluate the chromosome X
findings in other exposed populations.
A functional validation of DNA methylation targets using
gene expression was not performed in this cohort due
to the unavailability of field-collected RNA. To over-
come this limitation, we extracted gene expression in-
formation from multiple previously conducted studies
available in CTD. The increasing wealth of data in the
public arena now allows for the comparison of our
genome-wide signatures with those from other studies,
efficiently providing additional insight into key biologically-
relevant pathways. When the curated genes known to
interact or harbor differential expression upon BPA ex-
posure in the CTD were compared with the list of dif-
ferentially methylated genes in our study, more than
20% of BPA-associated genes were found to overlap.
The biologically-prioritized candidate gene, BEX2, is
associated with estrogen, cell cycle, and apoptosis path-
ways [69] and over-expressed in Ishikawa cells, a well-
differentiated human endometrial adenocarcinoma cells,
treated with BPA [70]. In addition, the biologically-
prioritized candidate, HOXA10, has previously been asso-
ciated with decreased DNA methylation among in utero
BPA-exposed mouse samples [71]. Altered methylation
at HOXA10 was confirmed by bisulfite pyrosequencing
in our Egyptian girls, despite relatively low BPA concen-
trations with small variation compared to US popula-
tions [27]. Although the validation did not result in the
same depth of significance as seen in the array data, it
showed a clear trend toward differential methylation
(Additional file 2: Figure S4). Importantly, some biologically-
prioritized candidate genes are known to target the
major disease pathways, such as DNA repair, cell cycle,
and development. Thus, future epigenetic epidemiology
studies with increased sample size and increased exposure
ranges are needed to further elucidate the consequences
of genome-wide altered methylation upon BPA exposure,
including BRCA1, BEX2, and HOXA10.
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BPA exposure levels in Egyptian pre-adolescent girls were
relatively low with less variability compared to age-matched
American girls; however, using a genome-wide methylation
approach, we identified alterations in saliva DNA methyla-
tion associated with BPA concentrations. Moreover, a
number of identified genes are important regulators in
developmental processes and/or disease susceptibility.
Pathways involved in metabolism, steroid hormone, thy-
roid disease, and immune response were also enriched
among differentially methylated genes. The integrative
analysis with data obtained from the CTD database identified
candidate genes, where epigenetic modifications may be as-
sociated with concomitant transcriptomic changes observed
upon BPA exposure. Although methylation is more suscep-
tible to environmental exposures during early development,
these data indicate that BPA may affect human health
through specific epigenomic modification of genes in rele-
vant pathways even throughout pre-adolescent development.
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Abbreviations
Avy: Viable yellow agouti; BPA: Bisphenol A; BMI: Body mass index;
Cabp: CDK5 activator-binding protein; CTD: Comparative Toxicogenomics
Database; DES: Diethylstilbestrol; DMRs: Differentially methylated regions;
DOHaD: Developmental origins of health and disease; EACs: Endocrine-active
compounds; EHMN: Edinburgh Human Metabolic Network; GO: Gene
ontology; GSEA: Gene set enrichment analysis; IGF2: Insuline-like growth
factor 2; IGF2R: Insulin like growth factor 2 receptor; IR: Insulin receptor;
KEGG: Kyoto Encyclopedia of Genes and Genomes; LIMMA: Linear models for
microarray data; LOD: Limit of detection; LRpath: Logistic regression based
pathway analysis tool; NDN: Necdin; NHANES: National Health and Nutrition
Examination Survey; Pde4d4: Phosphodiesterase type 4 variant 4;
PEG3: Paternally expressed 3; PWS: Prader-Willi/Angelman Syndrome;
RPMM: Recursively partitioned mixture model.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AH, ASS, DCD, IAS, and LSR conceived of this project and designed the study
protocols. AH, ASS, and IAS supervised and conducted field collection,
including subject recruitment. AMC was responsible for laboratory analysis of
BPA. JHK, MSN, and MAS performed statistical analysis. JHK, JAC, and CW
carried out pyrosequencing analysis. JHK, DCD, and LSR drafted themanuscript, and all authors edited and approved the final draft of the
manuscript.
Acknowledgements
This work was supported by the University of Michigan NIEHS Center of
excellence P30 ES017885 and by NIH grant ES017524. Support for CW, JAC,
and MSN was provided by NIEHS Institutional Training Grant T32 ES007062.
Support for JAC was also provided by NHGRI Institutional Training Grant T32
HG00040. We would like to acknowledge Dr. Antonia Calafat and her team
at the National Center for Environmental Health, Centers for Disease Control
and Prevention, Atlanta, GA for their part in the analysis of BPA
concentrations. We would also like to acknowledge Ms. Stacy Endres for her
effort in part of the data collection in Egypt and the Cancer Epidemiology
Education in Special Population Program Grant R25 CA112383. The authors
have no conflicts of interest and declare no competing financial interests.
Author details
1Department of Environmental Health Sciences, School of Public Health,
University of Michigan, Ann Arbor, MI, USA. 2Department of Otolaryngology,
University of Michigan, Ann ArborMI, USA. 3Department of Epidemiology,
University of Nebraska Medical Center, Nebraska, USA. 4Center for
Computational Medicine and Bioinformatics, University of Michigan, Ann
Arbor, MI, USA. 5Tanta Cancer Center and the Gharbiah Cancer Society,
Tanta, Egypt.
Received: 3 January 2013 Accepted: 2 April 2013
Published: 16 April 2013
References
1. Barker DJ: Intrauterine programming of coronary heart disease and
stroke. Acta Paediatra Suppl 1997, 423:178–182.
2. Barker DJP: Programming the baby. In Mothers, Babies, and Disease in Later
Life. 2nd edition. Edited by Barker DJP. Edinburgh: New York: Churchill
Livingstone; 1998:13–42.
3. Wojtyla A: Application of the hypothesis of Developmental Origin of
Health and Diseases (DOHaD) in epidemiological studies of women at
reproductive age and pregnant women in Poland. Ann Agric Environ Med
2011, 18:355–364.
4. Elston CW, Ellis IO: Normal structure and developmental abnormalities.
In The breast: systemic pathology. Volume 13. 3. Edited by Elston CW, Ellis IO.
Churchill Livingston: Edinburgh; 1998:1–19.
5. Russo J, Russo IH: Development of the human mammary gland. In The
mammary gland: development, regulation, and function. Volume 1. Edited by
Neville MC, Daniel CW. New York: Springer; 1987:67–93.
6. Daniel CW, Silberstein GB: Postnatal development of the rodent mammary
gland. In The mammary gland: development, regulation, and function. Volume 1.
Edited by Neville MC, Daniel CW. New York: Springer-Verlag; 1987.
7. McNally S, Martin F: Molecular regulators of pubertal mammary gland
development. Ann Med 2011, 43:212–234.
8. Russo J, Russo IH: Development of the human breast. Maturitas 2004,
49:2–15.
9. Li S, Hansman R, Newbold R, Davis B, McLachlan JA, Barrett JC: Neonatal
diethylstilbestrol exposure induces persistent elevation of c-fos expression
and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 2003,
38:78–84.
10. Li S, Washburn K, Moore R, Uno T, Teng C, Newbold R, McLachlan J, Negishi M:
Developmental exposure to diethylstilbestrol elicits demethylation of
estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 1997,
57:4356–4359.
11. Anway MD, Cupp AS, Uzumcu M, Skinner MK: Epigenetic transgenerational
actions of endocrine disruptors and male fertility. Science 2005, 308:1466–1469.
12. Anway MD, Leathers C, Skinner MK: Endocrine disruptor vinclozolin
induced epigenetic transgenerational adult-onset disease. Endocrinology
2006, 147:5515–5523.
13. Chang H-S, Anway MD, Rekow SS, Skinner MK: Transgenerational
epigenetic imprinting of the male germline by endocrine disruptor
exposure during gonadal sex determination. Endocrinology 2006,
147:5524–5541.
14. Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK:
Epigenetic transgenerational inheritance of altered stress responses.
Proc Natl Acad Sci USA 2012, 109:9143–9148.
Kim et al. Environmental Health 2013, 12:33 Page 14 of 15
http://www.ehjournal.net/content/12/1/3315. Nilsson E, Larsen G, Manikkam M, Guerrero-Bosagna C, Savenkova MI,
Skinner MK: Environmentally induced epigenetic transgenerational
inheritance of ovarian disease. PLoS One 2012, 7:e36129.
16. Ho S, Tang W, Belmonte de Frausto J, Prins G: Developmental exposure to
estradiol and bisphenol A increases susceptibility to prostate
carcinogenesis and epigenetically regulates phosphodiesterase type 4
variant 4. Cancer Res 2006, 66:5624–5632.
17. Dolinoy DC, Huang D, Jirtle RL: Maternal nutrient supplementation
counteracts bisphenol A-induced DNA hypomethylation in early
development. Proc Natl Acad Sci USA 2007, 104:13056–13061.
18. Yaoi T, Itoh K, Nakamura K, Ogi H, Fujiwara Y, Fushiki S: Genome-wide
analysis of epigenomic alterations in fetal mouse forebrain after
exposure to low doses of bisphenol A. Biochem Biophys Res Commun
2008, 376:563–567.
19. Anderson O, Nahar M, Faulk C, Jones T, Liao C, Kannan K, Weinhouse C,
Rozek L, Dolinoy D: Epigenetic responses following maternal dietary
exposure to physiologically relevant levels of bisphenol A. Environ Mol
Mutagen 2012, 53:334–342.
20. Dolinoy DC, Wiedman J, Waterland R, Jirtle RL: Maternal genistein alters
coat color and protects Avy mouse offspring from obesity by modifying
the fetal epigenome. Environ Health Perspect 2006, 114:567–572.
21. Maffini MV, Rubin BS, Sonnenschein C, Soto AM: Endocrine disruptors and
reproductive health: the case of bisphenol-A. Mol Cell Endocrinol 2006,
254–255:179–186.
22. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB,
Melzer D: Association of urinary bisphenol A concentration with medical
disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303–1310.
23. Trasande L, Attina TM, Blustein J: Association between urinary bisphenol A
concentration and obesity prevalence in children and adolescents.
JAMA 2012, 308:1113–1121.
24. Stahlhut RW, Welshons WV, Swan SH: Bisphenol A data in NHANES
suggest longer than expected half-life, substantial nonfood exposure, or
both. Environ Health Perspect 2009, 117:784–789.
25. Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S:
Environmental pollutants, diet, physical activity, body size, and breast
cancer: where do we stand in research to identify opportunities for
prevention? Cancer 2007, 109:2627–2634.
26. Colacino JA, Soliman AS, Calafat AM, Nahar MS, Van Zomeren-Dohm A,
Hablas A, Seifeldin IA, Rozek LS, Dolinoy DC: Exposure to phthalates
among premenstrual girls from rural and urban Gharbiah, Egypt: a pilot
exposure assessment study. Environ Health 2011, 10:40.
27. Nahar MS, Soliman AS, Colacino JA, Calafat AM, Battige K, Hablas A, Seifeldin IA,
Dolinoy DC, Rozek LS: Urinary bisphenol A concentrations in girls from rural
and urban Egypt: a pilot study. Environ Health 2012, 11:20.
28. Dey S, Zhang Z, Hablas A, Seifeldein IA, Ramadan M, El-Hamzawy H,
Soliman AS: Geographic patterns of cancer in the population-based
registry of Egypt: Possible links to environmental exposures. Cancer Epidemiol
2011, 35:254–264.
29. Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, El-Hamzawy H,
Wilson ML, Banerjee M, Boffetta P, et al: Urban–rural differences in breast
cancer incidence in Egypt (1999–2006). Breast 2010, 19:417–423.
30. Kriegel AM, Soliman AS, Zhang Q, El-Ghawalby N, Ezzat F, Soultan A,
Abdel-Wahab M, Fathy O, Ebidi G, Bassiouni N, et al: Serum cadmium
levels in pancreatic cancer patients from the East Nile Delta region of
Egypt. Environ Health Perspect 2006, 114:113–119.
31. Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, Rosenstein M,
Wiegers T, Mattingly CJ: The Comparative Toxicogenomics Database:
update 2011. Nucleic Acids Res 2011, 39:D1067–1072.
32. Davis AP, Murphy CG, Saraceni-Richards CA, Rosenstein MC, Wiegers TC,
Mattingly CJ: Comparative Toxicogenomics Database: a knowledgebase
and discovery tool for chemical-gene-disease networks. Nucleic Acids Res
2009, 37:D786–792.
33. Davis AP, Murphy CG, Rosenstein MC, Wiegers TC, Mattingly CJ: The
Comparative Toxicogenomics Database facilitates identification and
understanding of chemical-gene-disease associations: arsenic as a case
study. BMC Med Genomics 2008, 1:48.
34. Ghaly I, Hussein FH, Abdelghaffar S, Anwar G, Seirvogel RM: Optimal age of
sexual maturation in Egyptian children. East Mediterr Health J 2008,
14:1391–1399.
35. Soliman AS, Schairer C: Considerations in setting up and conducting
epidemiologic studies of cancer in middle- and low-income countries:the experience of a case–control study of inflammatory breast cancer in
North Africa in the past 10 years. Cancer Med 2012, 1:338–349.
36. Schairer C, Soliman AS, Omar S, Khaled H, Eissa S, Ben Ayed F, Khalafallah S,
Ben Ayoub W, Kantor ED, Merajver S, et al: Assessment of diagnosis of
inflammatory breast cancer cases at two cancer centers in Egypt and
Tunisia. Cancer Med 2013, 2:178–184.
37. Ye X, Kuklenyik Z, Needham LL, Calafat AM: Quantification of urinary conjugates
of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone
in humans by online solid phase extraction-high performance liquid
chromatography-tandem mass spectrometry. Anal Bioanal Chem 2005,
383:638–644.
38. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou LX, Shen R, Gunderson
KL: Genome-wide DNA methylation profiling using Infinium (R) assay.
Epigenomics-Uk 2009, 1:177–200.
39. Sartor MA, Dolinoy DC, Jones TR, Colacino JA, Prince ME, Carey TE, Rozek LS:
Genome-wide methylation and expression differences in HPV(+) and
HPV(-) squamous cell carcinoma cell lines are consistent with divergent
mechanisms of carcinogenesis. Epigenetics 2011, 6(6):777–787.
40. Smyth GK: Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat Appl Genet Mol Biol
2004, 3:Article 3.
41. Kim JH, Karnovsky A, Mahavisno V, Weymouth T, Pande M, Dolinoy DC, Rozek
LS, Sartor MA: LRpath analysis reveals common pathways dysregulated via
DNA methylation across cancer types. BMC Genomics 2012, 13:526.
42. Sartor MA, Leikauf GD, Medvedovic M: LRpath: a logistic regression
approach for identifying enriched biological groups in gene expression
data. Bioinformatics 2009, 25:211–217.
43. Thirlwell C, Eymard M, Feber A, Teschendorff A, Pearce K, Lechner M,
Widschwendter M, Beck S: Genome-wide DNA methylation analysis of
archival formalin-fixed paraffin-embedded tissue using the Illumina
Infinium HumanMethylation27 BeadChip. Methods 2010, 52:248–254.
44. Cotton AM, Lam L, Affleck JG, Wilson IM, Penaherrera MS, McFadden DE,
Kobor MS, Lam WL, Robinson WP, Brown CJ: Chromosome-wide DNA
methylation analysis predicts human tissue-specific X inactivation.
Hum Genet 2011, 130:187–201.
45. Banister CE, Koestler DC, Maccani MA, Padbury JF, Houseman EA, Marsit CJ:
Infant growth restriction is associated with distinct patterns of DNA
methylation in human placentas. Epigenetics 2011, 6:920–927.
46. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA,
Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment
analysis: a knowledge-based approach for interpreting genome-wide
expression profiles. Proc Natl Acad Sci USA 2005, 102:15545–15550.
47. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang
J, Marinelli B, Pesatori AC, et al: Changes in DNA methylation patterns in
subjects exposed to low-dose benzene. Cancer Res 2007, 67:876–880.
48. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC:
Global DNA hypomethylation is associated with high serum-persistent
organic pollutants in Greenlandic Inuit. Environ Health Perspect 2008,
116:1547–1552.
49. Kim KY, Kim DS, Lee SK, Lee IK, Kang JH, Chang YS, Jacobs DR, Steffes M,
Lee DH: Association of low-dose exposure to persistent organic
pollutants with global DNA hypomethylation in healthy Koreans.
Environ Health Perspect 2010, 118:370–374.
50. Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK, Huang Z,
Hoyo C, Midttun O, Cupul-Uicab LA, et al: 450 K Epigenome-Wide Scan
Identifies Differential DNA Methylation in Newborns Related to
Maternal Smoking During Pregnancy. Environ Health Perspect 2012,
120(10):1425–1431.
51. Woodruff TJ, Zota AR, Schwartz JM: Environmental chemicals in pregnant
women in the United States: NHANES 2003–2004. Environ Health Perspect
2011, 119:878–885.
52. Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y:
Direct evidence revealing structural elements essential for the high
binding ability of bisphenol A to human estrogen-related receptor-
gamma. Environ Health Perspect 2008, 116:32–38.
53. Vom Saal FS, Myers JP: Bisphenol A and risk of metabolic disorders.
JAMA 2008, 300:1353–1355.
54. Yoshino S, Yamaki K, Li X, Sai T, Yanagisawa R, Takano H, Taneda S, Hayashi
H, Mori Y: Prenatal exposure to bisphenol A up-regulates immune
responses, including T helper 1 and T helper 2 responses, in mice.
Immunology 2004, 112:489–495.
Kim et al. Environmental Health 2013, 12:33 Page 15 of 15
http://www.ehjournal.net/content/12/1/3355. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y,
Shimatsu A, Kuzuya H, Nakao K: Thyroid hormone action is disrupted by
bisphenol A as an antagonist. J Clin Endocrinol Metab 2002, 87:5185–5190.
56. Zoeller RT, Bansal R, Parris C: Bisphenol-A, an environmental contaminant
that acts as a thyroid hormone receptor antagonist in vitro, increases
serum thyroxine, and alters RC3/neurogranin expression in the
developing rat brain. Endocrinology 2005, 146:607–612.
57. Thayer KA, Heindel JJ, Bucher JR, Gallo MA: Role of environmental
chemicals in diabetes and obesity: a National Toxicology Program
workshop review. Environ Health Perspect 2012, 120:779–789.
58. Antonopoulos A, North SJ, Haslam SM, Dell A: Glycosylation of mouse and
human immune cells: insights emerging from N-glycomics analyses.
Biochem Soc Trans 2011, 39:1334–1340.
59. Sparrow LG, Lawrence MC, Gorman JJ, Strike PM, Robinson CP, McKern NM,
Ward CW: N-linked glycans of the human insulin receptor and their
distribution over the crystal structure. Proteins 2008, 71:426–439.
60. Chao HH, Zhang XF, Chen B, Pan B, Zhang LJ, Li L, Sun XF, Shi QH, Shen W:
Bisphenol A exposure modifies methylation of imprinted genes in mouse
oocytes via the estrogen receptor signaling pathway. Histochem Cell Biol
2012, 137:249–259.
61. Kang ER, Iqbal K, Tran DA, Rivas GE, Singh P, Pfeifer GP, Szabo PE: Effects of
endocrine disruptors on imprinted gene expression in the mouse
embryo. Epigenetics 2011, 6:937–950.
62. Jay P, Rougeulle C, Massacrier A, Moncla A, Mattei MG, Malzac P, Roeckel N,
Taviaux S, Lefranc JL, Cau P, et al: The human necdin gene, NDN, is
maternally imprinted and located in the Prader-Willi syndrome
chromosomal region. Nat Genet 1997, 17:357–361.
63. Gerard M, Hernandez L, Wevrick R, Stewart CL: Disruption of the mouse
necdin gene results in early post-natal lethality. Nat Genet 1999, 23:199–202.
64. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE,
Lumey LH: Persistent epigenetic differences associated with prenatal
exposure to famine in humans. Proc Natl Acad Sci USA 2008, 105:17046–17049.
65. Tobi EW, Slagboom PE, van Dongen J, Kremer D, Stein AD, Putter H,
Heijmans BT, Lumey LH: Prenatal famine and genetic variation are
independently and additively associated with DNA methylation at
regulatory loci within IGF2/H19. PLoS One 2012, 7:e37933.
66. Waterland RA, Lin JR, Smith CA, Jirtle RL: Post-weaning diet affects
genomic imprinting at the insulin-like growth factor 2 (Igf2) locus.
Hum Mol Genet 2006, 15:705–716.
67. Csankovszki G, Nagy A, Jaenisch R: Synergism of Xist RNA, DNA
methylation, and histone hypoacetylation in maintaining X chromosome
inactivation. J Cell Biol 2001, 153:773–784.
68. Willard HF: X chromosome inactivation, XIST, and pursuit of the X-inactivation
center. Cell 1996, 86:5–7.
69. Naderi A, Teschendorff AE, Beigel J, Cariati M, Ellis IO, Brenton JD, Caldas C:
BEX2 is overexpressed in a subset of primary breast cancers and
mediates nerve growth factor/nuclear factor-kappaB inhibition of
apoptosis in breast cancer cell lines. Cancer Res 2007, 67:6725–6736.
70. Naciff JM, Khambatta ZS, Reichling TD, Carr GJ, Tiesman JP, Singleton DW,
Khan SA, Daston GP: The genomic response of Ishikawa cells to
bisphenol A exposure is dose- and time-dependent. Toxicology 2010,
270:137–149.
71. Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS: Bisphenol-A exposure
in utero leads to epigenetic alterations in the developmental
programming of uterine estrogen response. FASEB J 2010, 24:2273–2280.
doi:10.1186/1476-069X-12-33
Cite this article as: Kim et al.: Bisphenol A-associated epigenomic
changes in prepubescent girls: a cross-sectional study in Gharbiah,
Egypt. Environmental Health 2013 12:33.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
